Tag: Terumo
Microvention officially rebrands to Terumo Neuro, reflecting “expanded focus and strategic...
Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced its official rebranding to Terumo Neuro, effective immediately.
This name change signifies a new...
NICE publishes a guidance supporting the use of selective internal radiation...
Terumo Europe recently shared that a positive guidance has been published by the National Institute for Health and Care Excellence (NICE) stating that selective...
Terumo Medical launches peripheral coil system in the USA
Terumo Medical, announces the launch of its new AZUR HydroPack peripheral coil system in the USA. The AZUR HydroPack coil system is a soft,...
PRIZER study to put the spotlight back on bare metal stents
This advertorial is sponsored by Terumo Interventional Systems.
Koen Deloose (Sint Blasius Hospital, Dendermonde, Belgium) talks to Interventional News about the importance of treating femoropopliteal...
Registry reinforces safety, efficacy and efficiency of radial access in visceral...
The final results of the RAVI prospective registry study demonstrated the safety and efficacy of radial access in visceral interventions in standard embolization procedures...
NICE publishes guidance supporting use of percutaneous ultrasound-guided microwave ablation for...
Terumo Europe has announced in a press release that it welcomes the guidance released by the National Institute for Health and Care Excellence (NICE) mentioning...
Terumo announces study results underscoring safety and efficacy of radial to...
Terumo Medical Corporation has announced late-breaking data showing the safety and efficacy of radial to peripheral (R2P) interventions with the R2P Misago self-expanding peripheral...
Holmium-166 SIRT demonstrates safety and efficacy in the treatment of HCC
University Medical Center Utrecht (Utrecht, Netherlands) recently published the latest results from the HEPAR Primary study, which evaluated the safety and efficacy of Holmium-166...
Occlusafe™-TACE improves response and reduces retreatment in HCC patients
NOTE: This video is ONLY available to watch in selected countries and geographies
Thierry De Baere (Villejuif, France) talks to Interventional News about the...
Terumo introduces Azur vascular plug and PG Pro peripheral microcatheter embolisation...
Terumo Medical Corporation has announced today the introduction of its Azur vascular plug. The addition to Terumo's embolisation portfolio is indicated for use to...
Roadsaver carotid stent system to receive reimbursement in France
The Roadsaver carotid stent system (Terumo France/Europe and MicroVention Europe) has been reimbursed in France. This follows the positive assessment from the French National...
HEPAR Primary study demonstrates safety of 166Ho-radioembolization in HCC, lays foundation...
This article is sponsored by Terumo Interventional Systems.
Holmium-166 (166Ho) radioembolization is a safe treatment option for patients with hepatocellular carcinoma (HCC), show results from...
TACE with drug-eluting microspheres as “safe and effective” as conventional TACE,...
The sustained release of anthracyclines and durable embolization from LifePearl microspheres (Terumo Europe) makes transarterial chemoembolization (TACE) with these embolic agents a safe and...
FDA approves MicroVention’s lower-profile WEB 17 intrasaccular aneurysm treatment device
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) for the Woven EndoBridge (WEB) 17 system from MicroVention, a US-based subsidiary...
PRIZER, new multicentre PAD study, launches
A new post-market study investigating the effectiveness of the Renzan peripheral stent system (Terumo) in patients with peripheral arterial disease (PAD) has been initiated....
Terumo acquires Quirem Medical
Terumo Corporation has announced it has completed the acquisition of Quirem Medical, a Netherlands-based healthcare start-up specialising in the development of next-generation microspheres for...
Combining targeted Holmium-166 radioembolization with systemic therapy improves response rates in...
This article is sponsored by Terumo.
The first prospective study on the combination of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and Holmium-166 (166Ho) radioembolization...
New randomised study investigating distal radial access, DISCO RADIAL, launches
Terumo has announced the launch of a new randomised clinical trial: the DIStal vs. COnventional RADIAL access trial (DISCO RADIAL). The trial compares the...
QuiremScout shows superior predictive value to technetium 99m macroaggregated albumin during...
A recent study comparing holmium-166 (QuiremSpheres, from Terumo) to technetium-99m-macroaggregated albumin (99mTc-MAA) as a work up for selective internal radiation therapy (SIRT) has found...
Orchestra BioMed announce FDA breakthrough device designation for Virtue sirolimus-eluting balloon
Orchestra BioMed, in partnership with Terumo Corporation, today announced that the company has secured breakthrough device designation by the US Food and Drug Administration...
Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra...
Orchestra BioMed and Terumo have formed a global strategic partnership for the development and commercialisation of Virtue sirolimus-eluting balloon (SEB) in the percutaneous coronary...
QuiremScout, the first and only product indicated for SIRT work-up, receives...
QuiremScout (Quirem Medical) has received CE mark, making it available for clinical centres throughout Europe. QuiremScout is designed to advance the SIRT (selective internal...
Terumo gets CE mark for Kanshas drug-coated balloon catheter for lower...
Terumo has announced receiving the CE mark for its Kanshas drug-coated balloon catheter used in the treatment of lower extremity peripheral arterial disease.
With...
Vascutek and Bolton Medical merge to become Terumo Aortic
Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into a single, integrated business, Terumo Aortic.
Vascutek and Bolton Medical merge to become Terumo Aortic
Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into a single, integrated business, Terumo Aortic.
Terumo to acquire large bore vascular closure device to expand its...
Terumo Corporation has announced that it has entered into an agreement to acquire assets related to the large bore vascular closure device, Xpro System,...
Terumo launches QuiremSpheres microspheres in Europe
Terumo has announced that it has launched QuiremSpheres microspheres in Europe on 18 September.
QuiremSpheres, the next generation of selective internal radiation therapy (SIRT) microspheres...
CIRSE launches Europe-wide study of transarterial chemoembolization with Terumo Lifepearl
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched its CIRSE Registry for LifePearl Microspheres (CIREL), a new European-wide observational study that...
First patient enrolled in new study of abbreviated DAPT post-stent in...
Gillian Jessurun (Treant Zorggroep, Scheper Hospital Emmen, The Netherlands) has enrolled the first patient in the investigator-initiated MASTER DAPT (Management of patients post bioresorbable...
Terumo announces first commercial clinical case using Quiremspheres
Terumo Europe NV has announced the first commercial clinical case using Quiremspheres—the next generation radioembolization microspheres for advanced unresectable liver cancer.
Quiremspheres are the only...
Gireesh Mukund Warawdekar
“Interventional radiology has always been characterised by its innovative spirit. We are now seeing progress with new procedures being developed to create percutaneous arteriovenous fistulae....
Terumo sets sight on Bolton to accelerate growth of vascular graft...
Terumo Corporation has announced that it has entered into a definitive agreement under which it has agreed to acquire Bolton Medical from its parent...
Terumo signs to acquire St Jude Medical and Abbott’s vascular closure...
Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion.
Based...
